ClinicalTrials.govpublic full text
SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer
advanced lung non-small cell carcinoma, metastatic lung non-small cell carcinoma, recurrent lung non-small cell carcinoma, stage iii lung cancer ajcc v8, stage iv lung cancer ajcc v8
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 287545
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.